However, the expression of CCL5 was not related to the other clinical factors including gender, age, clinical TNM stage, tumor differentiation, lymph node metastasis, or tumor length (Table 1). This evidence concerns the gene CCL5 and metastatic malignant neoplasm in the lymph nodes.